19
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Display of the human mucinome with defined O-glycans by gene engineered cells

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Mucins are a large family of heavily O-glycosylated proteins that cover all mucosal surfaces and constitute the major macromolecules in most body fluids. Mucins are primarily defined by their variable tandem repeat (TR) domains that are densely decorated with different O-glycan structures in distinct patterns, and these arguably convey much of the informational content of mucins. Here, we develop a cell-based platform for the display and production of human TR O-glycodomains (~200 amino acids) with tunable structures and patterns of O-glycans using membrane-bound and secreted reporters expressed in glycoengineered HEK293 cells. Availability of defined mucin TR O-glycodomains advances experimental studies into the versatile role of mucins at the interface with pathogenic microorganisms and the microbiome, and sparks new strategies for molecular dissection of specific roles of adhesins, glycoside hydrolases, glycopeptidases, viruses and other interactions with mucin TRs as highlighted by examples.

          Abstract

          Mucins play critical roles in maintaining the human microbiome, with their O-glycosylated tandem repeats (TRs) providing important cues for microbiota. Here, the authors develop a cellular platform for producing TRs with defined O-glycan structures to dissect the functions of TR O-glycosylation.

          Related collections

          Most cited references95

          • Record: found
          • Abstract: found
          • Article: not found

          Biological roles of glycans

          Ajit Varki (2016)
          Abstract Simple and complex carbohydrates (glycans) have long been known to play major metabolic, structural and physical roles in biological systems. Targeted microbial binding to host glycans has also been studied for decades. But such biological roles can only explain some of the remarkable complexity and organismal diversity of glycans in nature. Reviewing the subject about two decades ago, one could find very few clear-cut instances of glycan-recognition-specific biological roles of glycans that were of intrinsic value to the organism expressing them. In striking contrast there is now a profusion of examples, such that this updated review cannot be comprehensive. Instead, a historical overview is presented, broad principles outlined and a few examples cited, representing diverse types of roles, mediated by various glycan classes, in different evolutionary lineages. What remains unchanged is the fact that while all theories regarding biological roles of glycans are supported by compelling evidence, exceptions to each can be found. In retrospect, this is not surprising. Complex and diverse glycans appear to be ubiquitous to all cells in nature, and essential to all life forms. Thus, >3 billion years of evolution consistently generated organisms that use these molecules for many key biological roles, even while sometimes coopting them for minor functions. In this respect, glycans are no different from other major macromolecular building blocks of life (nucleic acids, proteins and lipids), simply more rapidly evolving and complex. It is time for the diverse functional roles of glycans to be fully incorporated into the mainstream of biological sciences.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions.

            The normal intestinal microbiota inhabits the colon mucus without triggering an inflammatory response. The reason for this and how the intestinal mucus of the colon is organized have begun to be unraveled. The mucus is organized in two layers: an inner, stratified mucus layer that is firmly adherent to the epithelial cells and approximately 50 μm thick; and an outer, nonattached layer that is usually approximately 100 μm thick as measured in mouse. These mucus layers are organized around the highly glycosylated MUC2 mucin, forming a large, net-like polymer that is secreted by the goblet cells. The inner mucus layer is dense and does not allow bacteria to penetrate, thus keeping the epithelial cell surface free from bacteria. The inner mucus layer is converted into the outer layer, which is the habitat of the commensal flora. The outer mucus layer has an expanded volume due to proteolytic activities provided by the host but probably also caused by commensal bacterial proteases and glycosidases. The numerous O-glycans on the MUC2 mucin not only serve as nutrients for the bacteria but also as attachment sites and, as such, probably contribute to the selection of the species-specific colon flora. This observation that normal human individuals carry a uniform MUC2 mucin glycan array in colon may indicate such a specific selection.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Mucins in cancer: protection and control of the cell surface.

                Bookmark

                Author and article information

                Contributors
                hclau@sund.ku.dk
                yoshiki@sund.ku.dk
                Journal
                Nat Commun
                Nat Commun
                Nature Communications
                Nature Publishing Group UK (London )
                2041-1723
                1 July 2021
                1 July 2021
                2021
                : 12
                : 4070
                Affiliations
                [1 ]GRID grid.5254.6, ISNI 0000 0001 0674 042X, Copenhagen Center for Glycomics, Departments of Cellular and Molecular Medicine and Odontology, Faculty of Health Sciences, University of Copenhagen, ; Copenhagen, Denmark
                [2 ]GRID grid.5477.1, ISNI 0000000120346234, Section Virology, Division of Infectious Diseases and Immunology, Department Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, ; CL Utrecht, the Netherlands
                [3 ]GRID grid.463764.4, ISNI 0000 0004 1798 275X, Architecture et Fonction des Macromolécules Biologiques, CNRS, Aix-Marseille Université, ; Marseille, France
                [4 ]GRID grid.5808.5, ISNI 0000 0001 1503 7226, Institute of Molecular Pathology and Immunology of the University of Porto/I3S, ; Porto, Portugal
                [5 ]GRID grid.5808.5, ISNI 0000 0001 1503 7226, Medical Faculty of the University of Porto, ; Porto, Portugal
                [6 ]GRID grid.152326.1, ISNI 0000 0001 2264 7217, Departments of Pharmacology and Biochemistry, Vanderbilt University, ; Nashville, TN USA
                [7 ]GRID grid.410372.3, ISNI 0000 0004 0419 2775, Department of Medicine, The San Francisco Veterans Affairs Medical Center, and the University of California, ; San Francisco, CA USA
                [8 ]GRID grid.266100.3, ISNI 0000 0001 2107 4242, The Glycobiology Research and Training Center, and the Department of Cellular and Molecular Medicine, University of California, ; San Diego, CA USA
                [9 ]GRID grid.412125.1, ISNI 0000 0001 0619 1117, Department of Biological Sciences, King Abdulaziz University, ; Jeddah, Saudi Arabia
                [10 ]GRID grid.510946.f, GlycoDisplay ApS, ; Copenhagen, Denmark
                Author information
                http://orcid.org/0000-0001-8811-2506
                http://orcid.org/0000-0001-7012-9836
                http://orcid.org/0000-0002-8192-2829
                http://orcid.org/0000-0001-7185-6680
                http://orcid.org/0000-0003-4207-9258
                http://orcid.org/0000-0001-8816-6352
                http://orcid.org/0000-0002-4459-9874
                http://orcid.org/0000-0002-3434-8588
                http://orcid.org/0000-0002-0418-5765
                http://orcid.org/0000-0002-0915-5055
                http://orcid.org/0000-0003-1428-5695
                Article
                24366
                10.1038/s41467-021-24366-4
                8249670
                34210959
                3b48d063-7867-4d12-b925-268541932b2b
                © The Author(s) 2021

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 22 October 2020
                : 8 June 2021
                Funding
                Funded by: FundRef https://doi.org/10.13039/501100001732, Danmarks Grundforskningsfond (Danish National Research Foundation);
                Award ID: DNRF107
                Award Recipient :
                Funded by: FundRef https://doi.org/10.13039/501100003554, Lundbeckfonden (Lundbeck Foundation);
                Categories
                Article
                Custom metadata
                © The Author(s) 2021

                Uncategorized
                glycobiology,glycoproteins,genetic engineering,glycosylation
                Uncategorized
                glycobiology, glycoproteins, genetic engineering, glycosylation

                Comments

                Comment on this article